These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29847773)

  • 1. Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway.
    Wandee J; Prawan A; Senggunprai L; Kongpetch S; Tusskorn O; Kukongviriyapan V
    Life Sci; 2018 Aug; 207():172-183. PubMed ID: 29847773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway.
    Wandee J; Prawan A; Senggunprai L; Kongpetch S; Kukongviriyapan V
    Life Sci; 2019 Jan; 217():155-163. PubMed ID: 30528773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derrischalcone suppresses cholangiocarcinoma cells through targeting ROS-mediated mitochondrial cell death, Akt/mTOR, and FAK pathways.
    Wandee J; Srinontong P; Prawan A; Senggunprai L; Kongpetch S; Yenjai C; Kukongviriyapan V
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Sep; 394(9):1929-1940. PubMed ID: 34086099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways.
    Jaidee R; Kongpetch S; Senggunprai L; Prawan A; Kukongviriyapan U; Kukongviriyapan V
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1681-1690. PubMed ID: 32383028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.
    Saengboonmee C; Seubwai W; Cha'on U; Sawanyawisuth K; Wongkham S; Wongkham C
    Anticancer Res; 2017 Jan; 37(1):115-123. PubMed ID: 28011481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.
    Yothaisong S; Dokduang H; Techasen A; Namwat N; Yongvanit P; Bhudhisawasdi V; Puapairoj A; Riggins GJ; Loilome W
    Tumour Biol; 2013 Dec; 34(6):3637-48. PubMed ID: 23832540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.
    Srijiwangsa P; Ponnikorn S; Na-Bangchang K
    BMC Pharmacol Toxicol; 2018 Jun; 19(1):32. PubMed ID: 29914576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways.
    Jaidee R; Kukongviriyapan V; Senggunprai L; Prawan A; Jusakul A; Laphanuwat P; Kongpetch S
    Life Sci; 2022 May; 296():120427. PubMed ID: 35218764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents.
    Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan U; Kukongviriyapan V
    Tumour Biol; 2016 Aug; 37(8):11495-507. PubMed ID: 27015836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
    Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
    Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial division inhibitor-1 potentiates cisplatin-induced apoptosis via the mitochondrial death pathway in cholangiocarcinoma cells.
    Tusskorn O; Khunluck T; Prawan A; Senggunprai L; Kukongviriyapan V
    Biomed Pharmacother; 2019 Mar; 111():109-118. PubMed ID: 30579250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
    Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
    J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway.
    Su CC; Hsieh KL; Liu PL; Yeh HC; Huang SP; Fang SH; Cheng WC; Huang KH; Chiu FY; Lin IL; Huang MY; Li CY
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.
    Hu MH; Huang TT; Chao TI; Chen LJ; Chen YL; Tsai MH; Liu CY; Kao JH; Chen KF
    Liver Int; 2018 Dec; 38(12):2248-2259. PubMed ID: 29797403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
    Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L
    Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo.
    Zhu HQ; Ma JB; Song X; Gao HJ; Ma CQ; Chang H; Li HG; Liu FF; Lu J; Zhou X
    Oncol Rep; 2016 Dec; 36(6):3488-3496. PubMed ID: 27779693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound C induces protective autophagy in human cholangiocarcinoma cells via Akt/mTOR-independent pathway.
    Zhao X; Luo G; Cheng Y; Yu W; Chen R; Xiao B; Xiang Y; Feng C; Fu W; Duan C; Yao F; Xia X; Tao Q; Wei M; Dai R
    J Cell Biochem; 2018 Jul; 119(7):5538-5550. PubMed ID: 29384220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin inhibits proliferation and enhances chemosensitivity of intrahepatic cholangiocarcinoma cell lines.
    Ling S; Feng T; Ke Q; Fan N; Li L; Li Z; Dong C; Wang C; Xu F; Li Y; Wang L
    Oncol Rep; 2014 Jun; 31(6):2611-8. PubMed ID: 24788596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells.
    Buranrat B; Senggunprai L; Prawan A; Kukongviriyapan V
    Life Sci; 2016 May; 153():41-9. PubMed ID: 27098189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.